4.5 Article

Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells

期刊

MOLECULAR AND CELLULAR BIOLOGY
卷 25, 期 5, 页码 1680-1695

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.25.5.1680-1695.2005

关键词

-

资金

  1. Medical Research Council [G117/379, G0100152] Funding Source: Medline
  2. Engineering and Physical Sciences Research Council [GR/R87901/01] Funding Source: researchfish
  3. Medical Research Council [G0100152, G117/379] Funding Source: researchfish
  4. MRC [G117/379, G0100152] Funding Source: UKRI

向作者/读者索取更多资源

While a significant amount is known about the biochemical signaling pathways of the Rho family GTPase Cdc42, a better understanding of how these signaling networks are coordinated in cells is required. In particular, the predominant subcellular sites where GTP-bound Cdc42 binds to its effectors, such as p21-activated kinase 1 (PAKI) and N-WASP, a homolog of the Wiskott-Aldritch syndrome protein, are still undetermined. Recent fluorescence resonance energy transfer (FRET) imaging experiments using activity biosensors show inconsistencies between the site of local activity of PAKI or N-WASP and the formation of specific membrane protrusion structures in the cell periphery. The data presented here demonstrate the localization of interactions by using multiphoton time-domain fluorescence lifetime imaging microscopy (FLIM). Our data here establish that activated Cdc42 interacts with PAKI in a nucleotide-dependent manner in the cell periphery, leading to Thr-423 phosphorylation of PAKI, particularly along the lengths of cell protrusion structures. In contrast, the majority of GFP-N-WASP undergoing FRET with Cy3-Cdc42 is localized within a transferrin receptor- and Rab11-positive endosomal compartment in breast carcinoma cells. These data reveal for the first time distinct spatial association patterns between Cdc42 and its key effector proteins controlling cytoskeletal remodeling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据